Accumulator and maximizer plans continue to take root in prescription cost-sharing economics. In a time when pharmaceutical margins are being compressed, patient cost-sharing is rising, and support budgets are strained, it is more important than ever for the industry to understand and quantify this impact. Download this report to review the data and understand the impact.